Innovations Day Highlights Drug-free Neuromodulation Therapy

Innovations Day Highlights Drug-free Neuromodulation Therapy

Development of drug-free technology to treat chronic conditions will be among the discussed topics when more than 200 worldwide entrepreneurs, industry leaders, and investment professionals meet for a daylong session on "Disruptive Innovation: The Driving Force of Progress in Neuromodulation."
The fifth Innovations Day takes place Sunday, 26 May 2019 at the International Convention Centre in Sydney, Australia, before the International Neuromodulation Society 14th World Congress.

Current developments in neuroscience and engineering accelerate emerging interventions and potential treatments, utilizing innovative neuromodulation methods, targets, frequencies, paradigms and principles.
The session intersperses presentations by emerging companies with keynote talks, and an executive panel addressing commercialization:
Early stage:
Attila Borbáth, CEO, Co-founder, Synergia Medical
Sjaak Deckers, PhD, CEO, GTX medical BV
Song-Song Liao, Founder/Interim CEO, Aldans Health
Stephen R. Popielarski, PhD, CEO, Thermaquil
Samuel Hamner, PhD, Director of Product Innovation, Cala Health
Intermediate stage:
Jason Hannon, CEO, Mainstay "The Challenges of Disruption in Neuromodulation for Chronic Low Back Pain: Addressing Cause vs. Symptoms"
Jonathan Ruais, CCO, Nalu "The Nalu Perspective on Increasing Patient Acceptance of the Therapy"
John Parker, PhD, Founder/CEO, Saluda "How to Repurpose Your Disruption into Other Potential Fields and Applications?"
Chad Andresen, VP of Marketing, StimRelieve "How to Re-energize a Field with Multiple Failed Trials: The Occipital Challenge?"
Advanced stage:
Keith Boettiger, Abbott
Marshall Stanton, MD, Medtronic
Paul Hanchin, Nuvectra
Laura Perryman, Stimwave
Maulik Nanavaty, PhD, Boston Scientific

Keynotes:
Josh Makower, MD, General Partner, NEA "Neuromodulation Innovation and Inspiration into the Next Century"
David Putrino, PhD, Mt. Sinai "Turning Neuromodulation on its Head: Fresh Perspectives on Interacting with the Nervous System"
Renee St. Amant, PhD, Innovator of the Year, Arm Limited "Bioelectronic Medicine as a Disruptive Technology"
Georgios Matis, MD, PhD, Cologne "Rediscovery of an Often Ignored Physiologic Signal: The Potential Source of Disruptive Innovation in Neuromodulation: What Can we Learn from Social Media Disrupting our Communication Style?"
James Cavuoto, Editor/Publisher, Neurotech Reports "Disruptive Innovation in Neuromodulation: Tips and Tricks in Determining Newsworthiness of Innovations"
About the International Neuromodulation Society
The nonprofit International Neuromodulation Society presents the full breadth of neuromodulation therapies through its website, its journal Neuromodulation: Technology at the Neural Interface, regional scientific meetings, and the biennial INS World Congress.

© Scoop Media